Pituitary tumorsPrognostic indicators

被引:18
作者
Wolfgang Saeger
机构
[1] University of Hamburg,Institute of Pathology of the Marienkrankenhaus Hamburg
关键词
Inactive adenoma; pituitary; tumor; adenoma; atypical adenoma; carcinoma;
D O I
10.1385/ENDO:28:1:057
中图分类号
学科分类号
摘要
Many factors influence the proliferation of pituitary adenomas: angiogenesis, apoptosis, growth factors, oncogenes, tumor suppressor genes, and hormone receptors. These elements can be demonstrated by immunohistochemistry and/or molecular pathology but no single factor can be used for determination of biological behavior resp. prognosis. Pituitary adenomas can be enclosed or invasive and may be very large or may be microadenomas, but the most important point for prognosis is the total resection in the first or second surgery or the reaction on treatments by drugs. Especially for residual tumor tissue proliferation, markers are important because they may indicate the growth rate and the aggressiveness of the tumor. Radiation therapy is indicated in many of these recurrent tumors and can improve the prognosis.
引用
收藏
页码:57 / 66
页数:9
相关论文
共 50 条
  • [31] The Genetics of Pituitary Adenomas
    Tatsi, Christina
    Stratakis, Constantine A.
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (01)
  • [32] Pituitary prolactin producing adenoma with ossification: A rare histological variant and review of literature
    Ke, Changshu
    Deng, Zhongduan
    Lei, Ting
    Zhou, Sheng
    Guo, Dong-sheng
    Wan, Jie
    Wu, Shimin
    NEUROPATHOLOGY, 2010, 30 (02) : 165 - 169
  • [33] Apoplexy in pituitary microadenomas
    Randall, Benjamin R.
    Couldwell, William T.
    ACTA NEUROCHIRURGICA, 2010, 152 (10) : 1737 - 1740
  • [34] Primary Pituitary Carcinoids Do Not Exist: A Reappraisal in the Era of Pituitary Neuroendocrine Tumours
    Armeni, Eleni
    Alexandraki, Krystallenia I.
    Roncaroli, Federico
    Grossman, Ashley B.
    ARCHIVES OF MEDICAL RESEARCH, 2023, 54 (08)
  • [35] Analysis of IMP3 Expression in Normal and Neoplastic Human Pituitary Tissues
    Alberto Righi
    Shuya Zhang
    Long Jin
    Bernd W. Scheithauer
    Kalman Kovacs
    Gabor Kovacs
    Miklos I. Goth
    Marta Korbonits
    Ricardo V. Lloyd
    Endocrine Pathology, 2010, 21 : 25 - 31
  • [36] Correlation of Pituitary Descent and Diabetes Insipidus After Transsphenoidal Pituitary Macroadenoma Resection
    Ma, Josh
    Gooderham, Peter
    Akagami, Ryojo
    Makarenko, Serge
    NEUROSURGERY, 2023, 92 (06) : 1269 - 1275
  • [37] PTTG is a Secretory Protein in Human Pituitary Adenomas and in Mouse Pituitary Tumor Cell Lines
    Takeo Minematsu
    Noboru Egashira
    Hanako Kajiya
    Mao Takei
    Susumu Takekoshi
    Yoshiko Itoh
    Hideo Tsukamoto
    Johbu Itoh
    Naoko Sanno
    Akira Teramoto
    Robert Yoshiyuki Osamura
    Endocrine Pathology, 2007, 18
  • [38] MEN1 and microRNAs: The link between sporadic pituitary, parathyroid and adrenocortical tumors?
    Nagy, Z.
    Szabo, P. M.
    Grolmusz, V. K.
    Perge, P.
    Igaz, I.
    Patocs, A.
    Igaz, P.
    MEDICAL HYPOTHESES, 2017, 99 : 40 - 44
  • [39] Focal radiation therapy for patients with persistent/recurrent pituitary adenoma, despite previous radiotherapy
    Edwards, Albert A.
    Swords, Francesca M.
    Plowman, P. N.
    PITUITARY, 2009, 12 (01) : 30 - 34
  • [40] PTTG is a secretory protein in human pituitary adenomas and in mouse pituitary tumor cell lines
    Minematsu, Takeo
    Egashira, Noboru
    Kajiya, Hanako
    Takei, Mao
    Takekoshi, Susumu
    Itoh, Yoshiko
    Tsukamoto, Hideo
    Itoh, Johbu
    Sanno, Naoko
    Teramoto, Akira
    Osamura, Robert Yoshiyuki
    ENDOCRINE PATHOLOGY, 2007, 18 (01) : 8 - 15